Pfizer Inc
NYSE: PFE
$25.65
+$0.52 (+2.1%)
Closing Price on November 22, 2024
PFE Articles
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
A few analysts released reports this past week calling for these three Dow stocks to rise even higher (at least 10%).
Published:
Last Updated:
The DJIA was headed for a nearly flat close Thursday, with Pfizer and UnitedHealth offsetting share price declines at Apple and DuPont.
Published:
Last Updated:
A few analysts released reports Wednesday calling for three Dow stocks to rise even higher. It seems at this rate that 23,000 is just around the corner.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Wednesday include Apple, Caterpillar, Pfizer, Royal Caribbean, Shopify, Under Armour and Walmart.
Published:
Last Updated:
Pharmaceuticals maker Pfizer reported second-quarter earnings before markets opened Tuesday, beating profit estimates by a penny a share, but coming up short on revenues.
Published:
Last Updated:
24/7 Wall St. has put together a quick preview Apple, Pfizer, Tesla and some of the other top companies reporting their latest quarterly results in the coming week.
Published:
Last Updated:
The July 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
These five top stocks rated Buy all pay good dividends and offer a degree of safety in what is clearly a very expensive market by historical standards.
Published:
Last Updated:
Major pharmaceutical companies have posted a relatively positive year so far. Currently, Johnson & Johnson (NYSE: JNJ) is leading the pack with Eli Lilly and Co. (NYSE: LLY) in a close second....
Published:
Last Updated:
Stocks were indicated marginally higher on Thursday after the European Central Bank statement remained quite dovish. The major equity indexes all remain just under all-time highs. Even though this...
Published:
Last Updated:
IBM, JPMorgan, Pfizer, and Merck were the poorest performing stocks among the Dow 30 on Monday.
Published:
Last Updated:
The June 30 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
In an incredible move on Friday, the FDA approved Endari for the treatment of patients age five and older with sickle cell disease to reduce severe complications that are common with the blood...
Published:
Last Updated:
The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks shrank.
Published:
Last Updated: